Efficacy and Safety of Intra-Articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled 13-Week Multi-Centre Study in Patients With Symptomatic Knee Osteoarthritis.
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Icatibant; Triamcinolone
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 16 Feb 2012 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 16 Feb 2012 Actual patient number is 590 according to ClinicalTrials.gov.
- 20 Apr 2007 Status changed from in progress to completed.